![The Asian Pacific Association for the Study of the Liver [APASL]](http://apasl.info/app-def/S-102/apasl/wp-content/themes/apasl/images/header/img_apasl_logo.png){kind=logo}
APASL Hepatology Webinar
The next APASL Hepatology Webinar will be held as follows!
Register at: https://regconf.com/apasl_webinar/
[Complimentary]
Certificate of attendance will be issued to the attendees.
The webinar will be broadcasted by APASL YouTube live stream!
https://www.youtube.com/channel/UC9b8afc00_jG9J0GBKmMpeQ
Dear Colleagues,
“We need hope but not false hope”
NEVER in the history of mankind should we be more united to confront a common deadly enemy-Covid-19. To win this war for human race, we need knowledge from at all fronts, be united for critical thinking and there should be no room for finger-pointing. Without immunity and any highly effective treatment, we can only anticipate more casualties directly or indirectly from COVID-19. So far, tremendous effort has been exercised to control new human transmission by social isolation and quarantine. However, this can only “flatten but not to eliminate the curve”. The cost of these measures is also tremendous making life. especially in the lower social sector, intolerable. We need to figure out a better solution to prevent and to treat COVID-19, as it is unlikely to go away shortly. On the other hand, we also need to have people back to work or to schooling safely. To this end, we have organized a series of webinar with experts in various field to enlightened us the most recent Asia-Pacific data in epidemiology, diagnostic test, treatment and measures to control infection transmission and fatality rate.
We look forward to your participation!
Yours sincerely
Masao Omata MD / George Lau MD
Conveners of APASL COVID-19 Taskforce
The previous sessions of APASL COVID-19 Webinar have been uploaded at APASL Official YouTube.
Please subscribe to our APASL channel!
APASL Official YouTube
https://www.youtube.com/channel/UC9b8afc00_jG9J0GBKmMpeQ
Bronze Sponsor
Sponsor
New articles on COVID-19
4 new articles on COVID-19 and the liverhave been
recently published onlinein Hepatology International.
1. Editorial: Fast, faster, and fastest: science on the run during COVID-19 drama"—"do not forget the liver: https://link.springer.com/article/10.1007/s12072-020-10042-0
2. Consensus: Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation: https://link.springer.com/article/10.1007/s12072-020-10043-z
3. Guidelines: Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI): https://link.springer.com/article/10.1007/s12072-020-10041-1
4. SARS-Cov-2 (human) and COVID-19: Primer 2020 https://link.springer.com/article/10.1007/s12072-020-10049-7
Empathy Letter
Dear colleagues,
We are writing on behalf of the APASL Leadership. The past several months have been a challenge not only to our subspecialty but for all allied subspecialties and personnel as we continue to afford a broader effort to help strengthen the global response to the novel coronavirus outbreak. We know that government interagency in each country and WHO have robust arrangements to monitor and managing this situation closely. We believe strongly that the region will emerge against the disease successfully. Keep safe and hope to see you soon.
Thank you.
------------------------------------
APASL Steering Committee
Dr. Shiv K Sarin, Dr. Rino Gani, Dr. Diana A. Payawal,
Dr. Tawesak Tanwandee, Dr. Lai Wei,
Dr. Darrell Crawford, Dr. A. Kadir Dokmeci, Dr. Jinlin Hou,
Dr. Ji-Dong Jia, Dr. Jia-Horng Kao, Dr. George Lau,
Dr. Laurentius A. Lesmana, Dr. Masao Omata, Dr. Teerha Piratvisuth,
Dr. Barjesh C. Sharma, Dr. Jose Sollano, Dr. Dong Jin Suh, Dr. Osamu Yokosuka
APASL Annual Meetings in Bangkok
Date: to be announced
City: Bangkok, Thailand
President: Dr. Tawesak Tanwandee
View APASL Annual Meetings in Bangkok Website
Welcome Message
"Dear friends and colleagues,
On behalf of Thai Association for Study of the Liver, it is our great pleasure to invite you to participate in the 30th Asian Pacific for The Study of Liver (APASL) in Bangkok, Thailand.
Since 1978, APASL has been actively striving towards the advancements of Hepatology studies. Our main objectives are to promote the latest scientific advancement and education of hepatology science, exchange of information and the development of consensus, encourage the practice of medicine in liver diseases and also coordinate scientific studies between various scientists and clinicians throughout the region.
APASL Bangkok will continue to reinforce these objectives, bringing together experts and veterans in the hepatology field from all around Asia Pacific, as well as in the world. The congress will feature a finely cultivated scientific programme, delivered by the best speakers, together with many interactive sessions and social programmes, promising the best platform for our participants to exchange knowledge and growth. Additionally, abstract competition and workshops will enhance the learning experience. APASL Bangkok will also be an excellent platform for industry players and trade companies to showcase the latest products and solutions.
The congress will be held in Bangkok, Thailand - the leading metropolitan area in Asia. You will enjoy a unique and inspiring experience with Thailand's distinctive culture and legendary hospitality.
We look forward to seeing you in Bangkok!"
"Liver Diseases in the Asia Pacific Region"
Dear APASL Members,
Please check "Liver Diseases in the Asia Pacific Region" published in The Lancet Gastroenterology and Hepatology on December 15. You will find it useful. Click on the image and access to the paper. If you like it, please share with your colleagues.
Hep-I OFFICIAL Twitter page has opened!
Hepatology International official Twitter page has opened!
You can check it out from the link below. Please follow us!
https://twitter.com/hepinternation1?s=20
You can also check out Hepatology International from here!
Call to Action for HCV Elimination Signed.
On November 10 at AASLD meeting, "Call to Action for Liver Association to Advance Progress Towards Viral Hepatitis Elimination: A Focus on Simplified Approaches to HCV Testing and Cure" was signed between AASLD, EASL, APASL, ALEH and acknowledgement of collaboration with CHAI, Clinton Health Access Initiative. As the number of patients of HCV is increasing all over the world, we have decided to work together to eliminate the patients until 2030. We are focusing on 4 specific themes that address the roles that liver associations and their constituents should play in eliminating HCV:
[Simplification] of diagnostic and treatment algorithms towards the goal of a one-stop "test and cure" for HCV
[Integration] of HCV treatment with primary care and other disease programs (e.g. TB, HIV) and outreach settings(harm reduction)
[Decentralization] of HCV services from large urban referral hospitals to local level care
[Task-sharing] of HCV care for Uncomplicated cases with primary care clinicians, medical officers, advanced practice clinicians, nurses, pharmacists and trained community health workers where available.
We continue working hard on eliminating HCV patients.
APASL Official YouTube Channel has been launched!
The APASL official YouTube Channel has been launched! You can watch the highlights of APASL scientific programs. Click on the image below and check it out!
Hep-I Impact Factor jumped up to 5.49!
Dear Colleagues,
Hepatology International, in association with Springer Nature, is extremely delighted to share with you the 2018 Impact Factor of HEPI which has touched a new high of 5.49 from 4.11 in 2017. More so, we have jumped into the TOP 20 Journals of Gastroenterology and Hepatology and are placed at position 17.
A significant feat for our journal indeed!
It never goes without saying that this would not have been possible without your support.
We look forward to grow together as a team and steer our journal, Hepatology International, towards a more purposeful space in the field of hepatology.
With best regards,
Prof Masao Omata / Prof. Shiv Sarin
SharedIt services: A boon for Authors/Researchers
SharedIt is part of Springer Nature initiative that allows authors to share their research to wider communities by enabling over 200 key media outlets and blogs to link to free-to-read versions of research articles. This media list has been significantly expanded to coincide with the expansion of the initiative across the Springer Nature portfolio. Many on this media list are aimed at the public, including BBC, The Economist, WIRED, The New York Times, as well as leading science bloggers.
Upon publication, corresponding authors are emailed a shareable link to view-only versions of their peer-reviewed research papers. All corresponding authors are sent this link, even those with papers published in open access journals. A stable, shortened URL is made available for published authors to share the full-text access to their paper by using the link http://rdcu.be/p2UW
Enhanced PDF: The link takes the author to a read-only enhanced PDF format of their published paper.
For open-access articles, all readers will be able to download, print and save an enhanced PDF, or to view the full-text HTML version.
For subscription articles, only subscribers will be able to download, print and save an enhanced PDF, or to view the full-text HTML version.
Authors can request shareable links of other research articles that they have authored with most Springer Nature journals by entering the article's DOI into our author portal
Springer Nature has a sample social media plan to help authors promote their research via Facebook and Twitter. The four-week campaign utilizes the SharedItlink to gain visibility through concentrated daily marketing, using both direct and indirect (post comments) methods.
For more Information please visit the SharedIt page on Springernature.com.
Future Meetings
APASL STC on Portal Hypertension in China
Date: 7-8 October, 2020 City: Guangzhou, China President: Dr. Xiaolong Qi Website: www.apaslstc.com |
 |
APASL STC on Alcohol Liver in India
Date: October 2-4, 2020 City: Gangtok, India President: Dr. M.R Kotwal Website: to be announced. |
APASL STC on Elimination of Hepatitis C in Myanmar
Date: December 5-6, 2020 City: Yangon, Myanmar President: Dr. Khin Maung Win Website: http://www.apaslstc2020yangon.com/ Hosting Organization: GI and Liver Foundation (GLF) (Myanmar) Conference President: Prof. Khin Maung Win Organizing Chairperson: Prof. Than Than Swe Organizing Vice-Chairs: Prof. Kyaw Soe Tun and Prof. Win Naing Academic Committee Chairperson: Prof. Khin Maung Win Conference Secretariat: Yangon GI and Liver Centre (YGLC) |
 |
APASL Annual Meeting in Bangkok
Date: February 4-6, 2021 City: Bangkok, Thailand President: Dr. Tawesak Tanwandee Website: https://www.apasl2021bangkok.org/ |
 |
APASL STC Osaka on Molecular Biology in Japan
Date: City: Osaka, Japan President: Dr. Norifumi Kawada Website: http://www.apaslstc-osaka2020.org/ |
 |
APASL STC on Critical Care in Hepatology: ACLF
Date: September 17-19, 2021 City: Wuhan, China President: Dr. Qin Ning Website: http://www.apaslstc2021wh.com |
 |
APASL STC on NAFLD/NASH: Non-Infection Epidemic in XXI
Date: October 8-10, 2021 City: Yerevan, Armenia President: Dr. Hasmik Ghazinian Website: to be announced. |
 |
APASL Oncology in Tokyo
Date: City: Tokyo, Japan President: Dr. Mitsuhiko Moriyama Website: http://www.apasl-oncology2020.org/ |  |
APASL STC on Advances in the Prevention and Management of Liver Cirrhosis and Its Complication
Date: June 11-12, 2021 City: Manila, Philippines President: Dr. Ian Homer Y. Cua Website: to be announced. |
APASL Annual Meeting in Korea
Date: March 30-April 3, 2022 City: COEX, Seoul, Korea President: Dr. Jin Mo Yang Website: to be announced. |
 |
Hep-I Impact Factor jumped up to 5.49!
Dear Colleagues,
Please be informed the Impact Factor of our Official Journal “Hepatology International” is now 5.49!
Masao Omata MD
Shiv K Sarin MD
Chief in Editor of Hepatology International
APASL Guidelines
The Guideline written by Dr. T Kanda has been published!
APASL Guidelines for HCC -”Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update” (Hepatol Int 2017; 11: 317-370)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for HBV -"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update" (Hepatol Int 2016; 10:1–98)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for HCV -”APASL consensus statements and recommendation for hepatitis C prevention, epidemiology, and laboratory testing” (Hepatol Int 2016 10:681–701)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for HCV -”APASL consensus statements and recommendation on treatment of hepatitis C” (Hepatol Int 2016 10:702–726)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for Acute-on-chronic Liver Failure -”Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014” (Hepatol Int 2014; 8: 453-471)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for Fibrosis -”Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)” (Hepatol Int 2009; 3: 323-333)
*This APASL Guideline can be downloaded by clicking below.
APASL consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis a 2016 update (Hepatol Int 2017 11:1–30)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for IPH -”Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment” (Hepatol Int 2007; 1: 398-413)
*This APASL Guideline can be downloaded by clicking below.
APASL Guidelines for Variceal Bleeding -”Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver” (Hepatol Int 2008; 2: 429-439)
*This APASL Guideline can be downloaded by clicking below.
APASL Fellowship 2020
The objective of the fellowship is to foster career development by encouraging the beneficial experience of working in a different clinical or research environment in another country in the Asia-Pacific region. These fellowships provide for advanced training in health and medical research in any country in the Asia-Pacific region and enable fellows to work in a clinical environment or on a research project with nominated advisers. We appreciate your generous contributions and support for these APASL fellowships and look forward to a number of high-quality applications for a 2020 fellowship.
An application form can be downloaded by clicking here: Click here! Please fill in and send to the APASL secretariat (apasl_secretariat@apasl.info). We are looking forward to receiving your application. There are no restrictions based on nationality. The sponsoring institution with the academic environment to provide adequate support for the proposed project might be suggested by APASL. Application will be reviewed by APASL Committee members. The decisions of the Committee are final and not subject to appeal.